Company Filing History:
Years Active: 2025
Title: Jiaojiao Li: Innovator in Biomedical Technology
Introduction
Jiaojiao Li is a prominent inventor based in Guangdong, China. She has made significant contributions to the field of biomedical technology, particularly in the development of chimeric antigen receptors. Her innovative work aims to enhance cancer treatment through targeted therapies.
Latest Patents
Jiaojiao Li holds a patent for a chimeric antigen receptor and its applications. This chimeric antigen receptor is designed to identify the malarial protein VAR2CSA and its related components. The receptor can target various tumor cells by binding to placental-like chondroitin sulfate A (pl-CSA) present on the surface of these cells. This innovative approach has the potential to improve therapeutic outcomes for patients with different types of tumors. She has 1 patent to her name.
Career Highlights
Jiaojiao Li is currently employed at Cas Lamvac (Guangzhou) Biomedical Technology Co., Ltd. Her role at the company allows her to work on cutting-edge research and development projects that focus on innovative biomedical solutions. Her expertise in chimeric antigen receptors positions her as a key player in the advancement of cancer therapies.
Collaborations
Jiaojiao Li collaborates with notable colleagues, including Wen Hu and Yongchao Yao. These partnerships enhance her research efforts and contribute to the overall success of their projects in the biomedical field.
Conclusion
Jiaojiao Li is a trailblazer in the realm of biomedical technology, with her innovative patent work paving the way for advancements in cancer treatment. Her contributions are vital to the ongoing development of targeted therapies that can significantly impact patient care.